tirzepatide va ozempic Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Let's settle this once and

Commercial availability typically follows FDA approval by several months

FDA labels for GLP-1 receptor agonists include warnings about increased risk of acute gallbladder disease, including cholecystitis and cholelithiasis, based on clinical trials and post-marketing data

If youre on immunosuppressants like tacrolimus or cyclosporine, your healthcare provider may need to check drug levels, as GLP-1 medications can alter how these drugs are processed

However, challenges persist, particularly concerning the cost of these medications

Juliette Cubanski, vice president and director of Medicare policy at KFF, put it plainly to CBS News: "In the short term, we have this temporary program, and then no clear path forward yet as to what will happen at the end of 2027." CMS Administrator Mehmet Oz framed the Bridge as a stopgap at launch, according to AJMC, but has not indicated when or whether a permanent mechanism will follow